Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
HS-38 is an inhibitor of death-associated protein kinase 1 (DAPK1; IC50 = 200 nM) and DAPK3.1 It selectively binds to DAPK1, DAPK2, and DAPK3 (Kds = 300, 79, and 280 nM, respectively) over Pim-1, Pim-2, and Pim-3 (Kds = 1,800, 6,500, and 810 nM, respectively) but does inhibit Pim-3 (IC50 = 200 nM). HS-38 (10 µM) inhibits phosphorylation of the DAPK3 target protein regulatory myosin light chain (RLC20) in primary human coronary artery smooth muscle cells. It reduces phenylephrine-induced contractions in isolated mouse aortic rings and increases the time to reach 50% maximal contractions in calyculin A-stimulated isolated rat caudal arterial smooth muscle strips when used at concentrations of 10 and 100 µM, respectively.
WARNING This product is not for human or veterinary use.
1. Fluorescence linked enzyme chemoproteomic strategy for discovery of a potent and selective DAPK1 and ZIPK inhibitor. ACS Chem. Biol. 8(12), 2715-2723 (2013).